Comparison of coagulation factors and blood loss between O and non-O blood types following hydroxyethyl starch infusion
- PMID: 20508790
- PMCID: PMC2876854
- DOI: 10.4097/kjae.2010.58.4.344
Comparison of coagulation factors and blood loss between O and non-O blood types following hydroxyethyl starch infusion
Abstract
Background: Individuals with type O blood are more likely to have reduced factor VIII and von Willebrand factor levels compared to their non-O counterparts. Hydroxyethyl starch (HES), which is widely used for blood volume replacement, can induce coagulopathy. Therefore, we tested whether blood type O patients show more coagulopathy and blood loss than non-O patients after infusion of 6% HES.
Methods: Thirty-four non-O and 20 type O patients scheduled for posterior lumbar interbody fusion (PLIF) involving 3 vertebrae or less from June 2007 to August 2008 were enrolled. Fifteen ml/kg of 6% HES was administered during the operation. Coagulation profiles was checked at pre-infusion (T0), 5 min after the end of infusion (T1), 3 hr after the end of infusion (T2), and 24 hr after the end of infusion (T3). Bleeding was measured during and after surgery for 24 hours.
Results: Baseline factor VIII concentration was lower and aPTT was longer in type O patients compared to those of non-O patients. 6% HES infusion decreased most of the coagulation factors at T1 in both groups, which were recovered in a time dependent manner. Factor VIII and aPTT of blood type O patients fell off the normal range at T1. However, other coagulation factors, thromboelastography variables, and blood loss were not different between the groups.
Conclusions: Despite inborn low factor VIII which further decreased shortly after HES infusion, blood type O patients did not show more blood loss than non-O blood type after 15 ml/kg of HES infusion in PLIF surgery.
Keywords: Blood loss; Blood type; Coagulation; Factor VIII; Hydroxyethyl starch; Thromboelastography.
Figures



Similar articles
-
Hemostatic and electrolyte effects of hydroxyethyl starches in patients undergoing posterior lumbar interbody fusion using pedicle screws and cages.Spine (Phila Pa 1976). 2010 Apr 1;35(7):829-34. doi: 10.1097/BRS.0b013e3181b8d9f2. Spine (Phila Pa 1976). 2010. PMID: 20072091 Clinical Trial.
-
The hemostatic profiles of patients with Type O and non-O blood after acute normovolemic hemodilution with 6% hydroxyethyl starch (130/0.4).Anesth Analg. 2006 Dec;103(6):1543-8. doi: 10.1213/01.ane.0000244533.81152.7a. Anesth Analg. 2006. PMID: 17122237
-
Intraoperative coagulation was more interfered by HES 200/0.5 than normal saline in off-pump coronary artery bypass surgery.J Cardiovasc Surg (Torino). 2008 Oct;49(5):679-84. J Cardiovasc Surg (Torino). 2008. PMID: 18670387
-
Coagulation disorders caused by hydroxyethyl starch.Thromb Haemost. 1997 Sep;78(3):974-83. Thromb Haemost. 1997. PMID: 9308738 Review.
-
Effects of different plasma substitutes on blood coagulation: a comparative review.Crit Care Med. 2001 Jun;29(6):1261-7. doi: 10.1097/00003246-200106000-00038. Crit Care Med. 2001. PMID: 11395618 Review.
Cited by
-
Blood Type O is not associated with increased blood loss in extensive spine surgery.J Clin Anesth. 2014 Sep;26(6):432-7. doi: 10.1016/j.jclinane.2014.01.019. Epub 2014 Aug 27. J Clin Anesth. 2014. PMID: 25172503 Free PMC article.
References
-
- Treib J, Baron JF, Grauer MT, Strauss RG. An international view of hydroxyethyl starches. Intensive Care Med. 1999;25:258–268. - PubMed
-
- Collis RE, Collins PW, Gutteridge CN, Kaul A, Newland AC, Williams DM, et al. The effect of hydroxyethyl starch and other plasma volume substitutes on endothelial cell activation; an in vitro study. Intensive Care Med. 1994;20:37–41. - PubMed
-
- Treib J, Haass A, Pindur G. Coagulation disorders caused by hydroxyethyl starch. Thromb Haemost. 1997;78:974–983. - PubMed
-
- Boldt J, Knothe C, Zickmann B, Andres P, Dapper F, Hempelmann G. Influence of different intravascular volume therapies on platelet function in patients undergoing cardiopulmonary bypass. Anesth Analg. 1993;76:1185–1190. - PubMed
-
- Innerhofer P, Fries D, Margreiter J, Klingler A, Kuhbacher G, Wachter B, et al. The effects of perioperatively administered colloids and crystalloids on primary platelet-mediated hemostasis and clot formation. Anesth Analg. 2002;95:858–865. - PubMed
LinkOut - more resources
Full Text Sources